Metatarsalgia describes pain beneath the metatarsal heads, commonly called pain in the ball of the foot. Your patients may describe aching, burning, bruising, or sharp discomfort that worsens with walking, running, prolonged standing, or push-off.
Runners, older adults, active workers, and patients with footwear or gait-related loading issues often present with this complaint. However, metatarsalgia represents a symptom pattern rather than one single diagnosis. Your first responsibility is to identify the structure under stress, rule out conditions that require referral, and then build a progressive plan around the patient’s mechanical demands.
JointWave™ can support that plan as a non-invasive adjunct for carefully selected patients. The goal is not to treat every case of forefoot pain with shockwave therapy. The goal is to use focused acoustic energy when the clinical presentation, examination, and treatment goals support it.
Localize the Pain. Exclude the Risk. Treat the Cause.
Start with the patient story
Ask your patient to identify the pain with one finger. Determine whether the symptoms sit directly beneath a metatarsal head, within an intermetatarsal space, around an MTP joint, or farther back toward the arch and heel.
Then clarify:
- When the pain began and whether training, work, or standing demands recently changed.
- Whether symptoms increase during push-off, running, barefoot walking, or narrow-shoe use.
- Whether the patient reports numbness, tingling, electric pain, or symptoms into the toes.
- Whether swelling, bruising, redness, or night pain occurs.
- Whether a previous injury, injection, surgery, or period of immobilization affected the area.
- What shoes, inserts, pads, or activity changes the patient has already tried.
Primary mechanical metatarsalgia often produces focal plantar tenderness under one or more metatarsal heads. Callus formation, altered gait, limited ankle dorsiflexion, cavus foot posture, hallux valgus, and reduced shock absorption can increase local loading.
A detailed review of forefoot disorders helps distinguish mechanical metatarsalgia from joint, nerve, bone, and soft-tissue conditions. DiPreta’s review of metatarsalgia and associated forefoot disorders provides a useful diagnostic framework for clinicians.
Screen the differential
Do not assume that every patient with ball-of-foot pain has uncomplicated metatarsalgia.
- Morton’s neuroma: Burning or shooting pain in an intermetatarsal space, toe paresthesia, and symptoms aggravated by narrow footwear suggest a nerve-related disorder. The diagnosis requires a focused examination and, when appropriate, imaging. Do not treat an assumed neuroma as generic metatarsal head overload.
- Stress fracture: Focal bony tenderness, recent training escalation, swelling, pain with impact, or pain that persists at rest should raise concern. Refer for appropriate imaging and medical evaluation before applying shockwave therapy.
- Plantar plate injury: Pain and swelling around an MTP joint, toe deviation, instability, or a positive drawer test can indicate plantar plate or capsular injury. Manage the injury according to its severity and consider referral when instability is present.
- Inflammatory or degenerative joint disease: Marked swelling, warmth, morning stiffness, multiple involved joints, or a history of gout or inflammatory arthritis requires a broader evaluation.
- Fat-pad atrophy: Older patients may report diffuse plantar tenderness with reduced cushioning beneath the metatarsal heads.
- Freiberg disease or other osseous pathology: Persistent pain around a metatarsal head, especially in younger patients, may require radiographs or advanced imaging.
- Proximal plantar pain: Pain centered near the heel rather than under the metatarsal heads suggests a different condition and should follow a separate diagnostic pathway.
Refer or co-manage when symptoms appear disproportionate, when infection or tumor is a concern, when neurovascular findings are present, or when the diagnosis remains unclear.
Explain the Evidence. Set the Standard.
The evidence for ESWT specifically in nonspecific metatarsalgia remains limited. The available literature includes small clinical series, studies of related forefoot disorders, and research with varied treatment parameters. That evidence does not establish a single gold-standard protocol for metatarsal head pain.
Research in related forefoot conditions offers useful context, but you should present it accurately. A systematic review of non-surgical treatments for Morton’s neuroma found that ESWT evidence was limited and did not demonstrate a statistically significant short-term advantage over sham treatment in the included trial. Read the systematic review in the Journal of Foot and Ankle Research.
That finding does not prove that ESWT has no role in every patient with forefoot pain. It does show why diagnosis, informed consent, outcome tracking, and realistic expectations matter.
At the same time, the evidence for ESWT is stronger in specific tendon and fascial conditions than in nerve-related forefoot pain. The NICE evidence overview for ESWT found sufficient evidence of efficacy to support the procedure for refractory plantar fasciitis, and a randomized sham-controlled trial also reported better outcomes with high-energy ESWT for chronic calcifying tendinitis of the rotator cuff (Gerdesmeyer et al., JAMA, 2003). Those results should not be transferred automatically to metatarsal head pain, but they do illustrate why condition-specific evidence and patient selection matter, and why metatarsalgia itself remains an area where the evidence is limited.
The proposed effects of shockwave therapy include pain modulation, changes in local tissue signaling, and support for blood flow and tissue remodeling. These mechanisms remain an area of ongoing research and should not become a substitute for clinical reasoning. A 2023 report on first MTP joint pain in runners discusses these mechanisms and the use of ESWT alongside physical therapy.
Begin Conservatively. Progress Intentionally. Reassess Often.
For a patient with a clear mechanical metatarsalgia presentation, consider JointWave as part of a broader care plan.
1. Reduce the active overload
Start by modifying the activity that reproduces symptoms. A runner may need a temporary reduction in mileage, speed work, hills, or forefoot-intensive drills. A patient who stands for long hours may benefit from scheduled seated breaks, supportive footwear, and a gradual return to full standing tolerance.
Do not prescribe complete inactivity unless the presentation warrants it. Preserve comfortable movement while reducing repeated irritation.
2. Combine treatment with mechanical support
JointWave should complement, not replace, mechanical correction.
✅ Use a metatarsal pad positioned proximal to the painful metatarsal heads to redistribute pressure.
✅ Recommend footwear with adequate toe-box width, appropriate cushioning, and a stable base.
✅ Consider orthotic guidance when arch mechanics, pressure distribution, or gait findings support it.
✅ Add calf mobility, foot-intrinsic strengthening, toe control, balance work, and graded loading as appropriate.
✅ Coordinate care with a podiatrist, physical therapist, or medical provider when the examination identifies a condition outside your scope.
Avoid placing a pad directly beneath the most painful metatarsal head. The goal is to redistribute load rather than increase focal pressure.
3. Apply JointWave with a measured protocol
No universally accepted ESWT schedule exists for generic metatarsalgia. Your protocol should reflect the patient’s irritability, tissue involved, chronicity, examination findings, and device guidance.
A practical framework includes:
- Use a series of weekly treatments rather than promising immediate relief from one visit.
- Begin at a low-to-moderate, patient-tolerable energy level.
- Use coupling medium and consistent contact to deliver acoustic energy accurately.
- Treat the clinically identified pain-generating region, which may include the plantar soft tissue around the metatarsal head or adjacent joint structures.
- Avoid aggressive treatment directly over a suspected stress fracture, acute tear, active infection, or unexplained swelling.
- Adjust intensity based on patient feedback and tissue response. Stronger is not automatically better.
- Reassess pain with walking, standing, push-off, and relevant functional tasks at each visit.
- Continue the home program and footwear strategy between sessions.
The JointWave interface helps your team manage treatment settings in a consistent, visible workflow. Its treatment heads are technologically superior and built to outlast major competitors, supporting better long-term ROI for your practice.
Explain Soreness. Explain Timing. Explain the Plan.
Patients need clear guidance before the first session.
Tell your patient that treatment may feel intense or tender over the target area. Temporary soreness, localized tenderness, redness, mild bruising, or altered sensation can occur after ESWT. These effects generally remain localized and short-lived, but the patient should contact your office if pain becomes severe, progressive, or unusual.
The NICE evidence overview for ESWT describes ESWT as a non-surgical procedure with generally manageable adverse effects, while also emphasizing variation in efficacy and the need for appropriate consent. Although the overview addresses refractory plantar fasciitis rather than metatarsalgia, it provides useful safety and communication principles for the modality.
Set expectations around gradual change:
- The patient may notice temporary tenderness after treatment.
- Early pain modulation does not necessarily indicate tissue recovery.
- Functional improvement may develop over several weeks as the patient continues activity modification, footwear changes, and progressive exercise.
- Some patients respond slowly or incompletely.
- A lack of meaningful improvement should trigger reassessment of the diagnosis and loading strategy.
Track more than a pain score. Document walking tolerance, standing tolerance, running progression, footwear tolerance, push-off, callus changes, and patient-specific goals.
Make the Protocol Practice-Ready
A successful JointWave program requires more than a device. Your staff needs a repeatable workflow for screening, consent, treatment preparation, documentation, follow-up, and patient education.
JointWave supports implementation with installation, staff training, and marketing materials. That allows your team to introduce a non-invasive, drug-free option without forcing it into your existing care plan. You can position the service around appropriate patient selection, measurable functional goals, and coordinated conservative care.
A consistent protocol can help your clinic:
✅ Add a practical option for patients who want to avoid injections or surgery.
✅ Complement adjustments, mobility work, orthotic guidance, and rehabilitation.
✅ Create a more structured care pathway for chronic, activity-limiting forefoot pain.
✅ Offer a cash-based service that fits within an established chiropractic workflow.
Know When to Stop. Know When to Refer. Know When to Reassess.
JointWave should not delay appropriate evaluation. Pause treatment and refer when:
- The patient has focal bony pain or signs consistent with a stress fracture.
- The examination suggests a significant plantar plate injury or unstable MTP joint.
- The patient reports progressive numbness, weakness, or neurovascular changes.
- Swelling, warmth, redness, fever, or systemic symptoms raise concern for infection or inflammatory disease.
- Symptoms worsen despite appropriate load management.
- The diagnosis remains uncertain after examination.
Metatarsalgia requires precision. Diagnose the pain pattern, reduce the mechanical stress, use JointWave judiciously, and measure function over time. This approach gives your patient a clearer plan and gives your practice a defensible, evidence-informed protocol.
Test JointWave in Your Clinic. Decide with Confidence.
Bring JointWave into your treatment room and evaluate how it fits your patients, staff, and care plans. Start your 30-day risk-free, no-obligation in-office trial today. Request your JointWave trial at jointwavetrial.com.